LINC01845

Across TCGA pan-cancer cohorts, LINC01845 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated LINC01845 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher LINC01845 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01845 expression acts as an unfavorable survival marker, although some lineages such as LAML and PAAD show a favorable association.

READ, STAD, and BLCA are the cancer types where LINC01845 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Tertile	II,III,IV	0.366	0.811	<.001	69	view →
STAD	DFS	Median	III,IV	0.198	0.452	.007	57	view →
BLCA	DFS	Tertile	III,IV	0.174	0.508	.001	36	view →
LAML	DFS	Quartile	All	0.710	0.210	.002	30	view →
KIRC	OS	Tertile	All	0.525	0.662	.008	27	view →
PAAD	OS	Tertile	All	0.814	0.399	.005	24	view →
MESO	DFS	Quartile	All	0.206	0.397	.003	24	view →
SKCM	OS	Tertile	III,IV	0.133	0.410	<.001	21	view →
DLBC	OS	Tertile	All	0.516	1.000	.024	19	view →
PCPG	DFS	Tertile	All	0.323	0.875	.005	15	view →
THCA	OS	Tertile	IV	0.871	1.000	.008	12	view →
CHOL	OS	Median	II,III,IV	0.080	0.740	.026	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

LINC01845–READ (DFS)

Open the READ breakdown →